Back

Dysregulation of "Don't Eat Me" Signaling-Related Genes in Sepsis: A Targeted Transcriptomic Analysis

Dang, Y.; Kong, J.

2026-02-26 bioinformatics
10.64898/2026.02.25.707968 bioRxiv
Show abstract

Sepsis remains a life-threatening condition with limited therapeutic options targeting immune dysregulation. The CD47-SIRP "dont eat me" signaling axis, well characterized in tumor immune evasion, has not been systematically investigated in the context of sepsis. In this study, we performed a targeted transcriptomic analysis of phagocytosis- and "dont eat me" -related genes using the GSE228541 dataset (14 sepsis patients, 15 healthy controls). We identified 8 significantly differentially expressed genes within the curated gene panel. Key changes included downregulation of CD47 (logFC = -0.88, FDR = 5.6 x 10-4) and marked upregulation of PRTN3 (logFC = 2.68, FDR = 6.1 x 10-4). Gene Ontology (GO) enrichment demonstrated prominent alterations in pathways including negative regulation of phagocytosis (GO:0050765, FDR = 7.6 x 10-22), endocytosis, and inflammatory responses. Co-expression network analysis identified SNX3, DYSF, and PLSCR1 as hub genes within this regulatory module. Immune infiltration analysis showed increased M1 macrophage polarization and neutrophil activation in sepsis. Using LASSO regression, we constructed a 6-gene diagnostic signature (PLSCR1, SNX3, DYSF, PRTN3, CSK, CD47) that discriminated sepsis from controls with good performance (AUC = 0.933 in the test subset). Downregulation of CD47 suggests impaired "self" recognition, which may contribute to aberrant phagocytosis during sepsis. Elevated PRTN3 is consistent with neutrophil activation and extracellular trap formation, linking innate immune activation to tissue injury. This targeted transcriptomic analysis reveals coordinated transcriptional reprogramming of phagocytosis-regulatory genes in sepsis and supports the CD47-SIRP axis as a candidate therapeutic target for further investigation.

Matching journals

The top 10 journals account for 50% of the predicted probability mass.

1
International Journal of Molecular Sciences
453 papers in training set
Top 0.1%
14.7%
2
Frontiers in Immunology
586 papers in training set
Top 0.7%
8.6%
3
International Immunopharmacology
15 papers in training set
Top 0.1%
7.4%
4
Scientific Reports
3102 papers in training set
Top 13%
7.0%
5
Frontiers in Genetics
197 papers in training set
Top 2%
3.7%
6
Journal of Leukocyte Biology
40 papers in training set
Top 0.1%
2.2%
7
Frontiers in Cell and Developmental Biology
218 papers in training set
Top 3%
2.1%
8
Frontiers in Physiology
93 papers in training set
Top 2%
2.1%
9
Cell Death & Disease
126 papers in training set
Top 0.6%
2.1%
10
PLOS ONE
4510 papers in training set
Top 50%
1.9%
50% of probability mass above
11
Brain, Behavior, and Immunity
105 papers in training set
Top 1%
1.9%
12
Biomedicines
66 papers in training set
Top 0.7%
1.8%
13
Journal of Thrombosis and Haemostasis
28 papers in training set
Top 0.4%
1.7%
14
eLife
5422 papers in training set
Top 45%
1.5%
15
Glia
74 papers in training set
Top 0.3%
1.5%
16
JCI Insight
241 papers in training set
Top 4%
1.4%
17
Nature Communications
4913 papers in training set
Top 56%
1.3%
18
iScience
1063 papers in training set
Top 21%
1.3%
19
Disease Models & Mechanisms
119 papers in training set
Top 2%
1.1%
20
Cell Communication and Signaling
35 papers in training set
Top 0.7%
1.0%
21
The Journal of Infectious Diseases
182 papers in training set
Top 4%
0.9%
22
Frontiers in Medicine
113 papers in training set
Top 5%
0.9%
23
Journal of Neurotrauma
27 papers in training set
Top 0.5%
0.8%
24
Frontiers in Microbiology
375 papers in training set
Top 8%
0.8%
25
Critical Care
14 papers in training set
Top 0.5%
0.8%
26
PLOS Pathogens
721 papers in training set
Top 9%
0.7%
27
PLOS Computational Biology
1633 papers in training set
Top 25%
0.7%
28
PeerJ
261 papers in training set
Top 16%
0.7%
29
Frontiers in Molecular Biosciences
100 papers in training set
Top 6%
0.7%
30
Journal of Experimental Medicine
106 papers in training set
Top 4%
0.7%